aTyr Pharma Stock Forecast NASDAQ:LIFE

Price Target and Analyst Ratings

Most Recent Rating

On September 14, 2021 "Oppenheimer" gave "$14.00 - $20.00" rating for LIFE. The price target was set to $9.15+67.0%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-09-14	$14.00 - $20.00	Target Raised by	Oppenheimer	$9.00	$9.15+67.0%
2021-09-13	$13.00 - $18.00	Target Raised by	HC Wainwright	$9.15	$7.39+34.9%
2021-09-13	$20.00 - $21.00	Target Raised by	Roth Capital	$9.15	$10.11+84.5%
2021-06-30	Buy	Reiterated by	Jonestrading	$4.88	$15.00
2021-05-24	Buy	Initiated by	Jonestrading	$4.15	$15.00
2021-05-18	Buy	Initiated by	Jonestrading	$3.96	$15.00
2021-05-18	Buy	Initiated by	Jonestrading	$3.96
2021-05-10	Buy	Initiated by	Laidlaw	$3.67	$18.00
2021-05-10	Buy	Initiated by	Laidlaw	$3.67
2021-03-30	Outperform	Target Raised by	Oppenheimer	$4.39	$12.00 → $14.00
2021-03-24	Buy	Reiterated by	Oppenheimer	$4.66	$12.00 → $14.00
2021-03-24	Buy	Reiterated by	Oppenheimer	$4.66	$14.00
2021-03-22	Buy	Target Raised by	Roth Capital	$5.32	$15.00 → $20.00
2021-03-16	Positive - Buy	Target Raised by	Roth Capital	$6.14	$15.00 → $20.00
2020-09-22	Buy	Reiterated by	Oppenheimer	$3.89
2020-08-17	Neutral - Buy	Upgraded by	HC Wainwright	$4.17	$13.00
2020-06-16	Buy	Reiterated by	Oppenheimer	$3.83	$8.00
2020-05-13	Buy	Reiterated by	Oppenheimer	$3.71	$8.00
2020-04-21	Hold	Reiterated by	HC Wainwright	$3.25

LIFE Stock Trend

Given the current short-term trend, the stock is expected to rise 28.25% during the next 3 months and, with a 90% probability hold a price between $7.34 and $13.16 at the end of this 3-month period.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$5.76	$8.03	$10.30
2021-09-21	$5.80	$8.07	$10.33
2021-09-22	$5.83	$8.10	$10.37
2021-09-23	$5.87	$8.14	$10.40
2021-09-24	$5.91	$8.17	$10.44
2021-09-27	$5.94	$8.21	$10.48
2021-09-28	$5.98	$8.24	$10.51
2021-09-29	$6.01	$8.28	$10.55
2021-09-30	$6.05	$8.32	$10.58
2021-10-01	$6.09	$8.35	$10.62
2021-10-04	$6.12	$8.39	$10.65
2021-10-05	$6.16	$8.42	$10.69
2021-10-06	$6.19	$8.46	$10.73
2021-10-07	$6.23	$8.50	$10.76
2021-10-08	$6.26	$8.53	$10.80
2021-10-11	$6.30	$8.57	$10.83
2021-10-12	$6.34	$8.60	$10.87
2021-10-13	$6.37	$8.64	$10.91
2021-10-14	$6.41	$8.67	$10.94
2021-10-15	$6.44	$8.71	$10.98
2021-10-18	$6.48	$8.75	$11.01
2021-10-19	$6.52	$8.78	$11.05
2021-10-20	$6.55	$8.82	$11.09
2021-10-21	$6.59	$8.85	$11.12
2021-10-22	$6.62	$8.89	$11.16
2021-10-25	$6.66	$8.93	$11.19
2021-10-26	$6.70	$8.96	$11.23
2021-10-27	$6.73	$9.00	$11.26
2021-10-28	$6.77	$9.03	$11.30
2021-10-29	$6.80	$9.07	$11.34

About aTyr Pharma

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. The company develops Resolaris, which is in Phase Ib/II clinical trials for treating adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic myopathy with an immune component; patients with early onset FSHD; and adult patients with limb-gir... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!